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In the human epidermis, the cells most at risk for the
development of cancer due to sunlight exposure are the
keratinocytes. In animal models, ultraviolet-B is a
complete carcinogen, capable of inducing and promot-
ing the development of malignant cells. A key element
of ultraviolet-B-induced carcinogenesis is the ability of
ultraviolet-B to induce the expression of a number of
cellular proteins and activate growth factor receptor
tyrosine kinases, including the erbB receptor family.
Keratinocytes express the erbB1 (also called EGF-R,
HER1), the erbB2 (also known as neu or HER2), and
the erbB3 (HER3) subtypes. In general, activation of
the erbB receptor family leads to a cellular proliferative
response. In certain instances, however, activation of an
erbB receptor can induce di¡erentiation, cell cycle ar-
rest, and even apoptosis. The inhibition of tyrosine ki-
nase activity in rodent models and human skin has
been shown to inhibit some ultraviolet-B response
pathways.We have shown that the inhibition of erbB re-
ceptors, by both pharmaceutical and immunologic
means, will inhibit ultraviolet-B-induced apoptosis in
the HaCaT human keratinocyte cell line. This inhibi-
tion was speci¢c for the erbB receptor family and spe-
ci¢c for ultraviolet-B-induced apoptosis. These results
suggest that, in certain instances, ultraviolet-B-induced
apoptotic signaling requires erbB family receptor
activity. Key words: UVB/keratinocytes/apoptosis/erbB.
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T
he e¡ects of solar radiation on the epidermis have
been well documented in both humans and animal
model systems (Tyrrell, 1994; de Gruijl, 1999). These
studies have determined that the risk of developing
nonmelanoma skin cancer is unmistakably linked to
exposure of the epidermis to the ultraviolet spectrum of solar ra-
diation (Ziegler et al, 1994; Brash, 1997). In humans, the presence
of mutations in tumors that are speci¢cally linked to exposure to
ultraviolet-B (UVB) irradiation provides evidence that sun expo-
sure is a cause of nonmelanoma skin cancer. As these linkage stu-
dies can only be done retrospectively, it is di⁄cult to determine
the progression of individual skin cancers or determine the me-
chanism of carcinogenesis. Therefore, in vitro systems have been
invaluable in elucidating the response of human keratinocytes to
UVB exposure.
Because of the di⁄culties in working with primary normal
human keratinocytes (NHK), the HaCaT keratinocyte cell line
has been widely used as a surrogate to examine the e¡ects of
UVB on keratinocyte cultures (Boukamp et al, 1988). HaCaT cells
were derived from skin as a spontaneously immortalized cell line
that still retains the ability to undergo di¡erentiation. In many
ways, HaCaTcells respond to UVB exposure in a manner similar
to normal keratinocytes (Henseleit et al, 1996; 1997; Petit-Frere
et al, 2000). For example, both normal keratinocytes and HaCaT
cells undergo UVB-induced apoptosis in a time- and dose-de-
pendent manner. HaCaT cells also secrete various cytokines fol-
lowing UVB irradiation, again similar to normal keratinocytes
(Petit-Frere et al, 2000). Therefore, it is appropriate to use HaCaT
cells as a model for the response of human keratinocytes to UVB
irradiation.
Over the past several years, it has become apparent that a major
factor controlling the response of keratinocytes to UVB exposure
is the receptor for epidermal growth factor (EGFr) (Bender et al,
1997; Jost et al, 2000; Peus et al, 2000). Activation of this receptor
has been linked to continued cell proliferation in cell culture and
the survival of keratinocytes following UVB irradiation (Peus
et al, 2000; Jost et al, 2001b). Interestingly, irradiation of keratino-
cytes with UVB leads to the ligand-independent activation of
EGFr (Sachsenmaier et al, 1994; Huang et al, 1996). The EGFr is
but one member of a family of type I tyrosine kinase receptors,
however, that share extensive amino acid homology (Jost et al,
2000; Olayioye et al, 2000; Bogdan and Klambt, 2001; Yarden
and Sliwkowski, 2001). Currently, four members of the erbB re-
ceptor family have been described: erbB1 (the EGFr), erbB2,
erbB3, and erbB4. Recently, studies examining the expression
and function of these receptors in the skin have been initiated.
Several investigators have reported that normal skin, primary hu-
man keratinocytes, and HaCaT cells all express the erbB1, erbB2,
and erbB3 receptors (Marques et al, 1999; de Potter et al, 2001;
Stoll et al, 2001). Weak expression of erbB4 has also been de-
scribed from all of these sources (Marques et al, 1999). It is unclear,
however, what the functional consequences of di¡erential erbB
family member activation on UVB-induced responses are. For
example, UVB irradiation leads to the activation of the erbB2 re-
ceptor in a manner similar to the erbB1, but the details describing
this activation have not been described (Huang et al, 1996). There-
fore, the objective of these studies was to examine the response
of human keratinocytes to UVB irradiation following the
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inhibition of the erbB receptor family of tyrosine kinases. Our
¢ndings demonstrate that the inhibition of erbB receptors in
HaCaT cells leads to a protection from UVB-induced apoptosis.
MATERIALS AND METHODS
Reagents Pharmacologic inhibitors AG 825 (4-hydroxy-3-methoxy-
5-(benzothiazolylthiomethyl)-benzylidenecyanoacetamide), AG 1295
(6,7-dimethyl-2-phenylquinoxaline), AG 1478 (4-(3-chloroanilino)-6,7-
dimethoxyquinazoline), and neutralizing antibodies to erbB1 (clone 528)
and erbB2 (clone 9G6) were all obtained from Calbiochem, La Jolla, CA.
4,5-Dianilinophthalimide (DAPH) was obtained from Sigma, St. Louis,
MO. All other chemicals were obtained from Sigma or Roche Molecular
Biochemicals, Indianapolis, IN.
HaCaTcell culture HaCaT keratinocyte cells were grown in Dulbecco’s
modi¢ed Eagle’s medium (Irvine Scienti¢c, Santa Ana, CA) supplemented
with 10% fetal bovine serum (Nova-Tech, Grand Island, NY) and 1000 U
penicillin, streptomycin (Roche). Cells were grown to approximately 80%
con£uence before experiments were carried out.
UVB irradiation UVB irradiation of HaCaT cells was accomplished
using a Philips F20T12/UV-B source (270^390 nm; containing 2.6%
UVC, 43.6% UVB, 53.8% UVA). The intensity of the UVB source was
measured prior to each experiment using an IL1700 radiometer and an
SED240 UVB detector (International Light, Newburyport, MA) at a
distance of 8 cm from the UVB source to the monolayer of cells. HaCaT
cells were irradiated in phosphate-bu¡ered saline, after which the original
medium, with or without supplements, was returned to each culture dish.
Caspase 3 assay Caspase 3 proteolytic activity was measured in HaCaT
cell lysates using a synthetic £uorogenic substrate (DEVD-AMC, Alexis
Biochemicals, San Diego, CA) as previously described (Nicholson et al,
1995; Hurwitz and Spandau, 2000). Brie£y, the HaCaT cell pellet was
suspended in lysis bu¡er [50 mM PIPES pH 7.0, 50 mM KCl, 5 mM
ethyleneglycol-bis(b-aminoethyl ether)-N,N,N0,N0-tetraacetic acid, 2 mM
MgCl2, 1 mM dithiothreitol (DTT)], subjected to one freezethaw cycle,
and placed on ice. Any cellular debris was removed by centrifugation. An
aliquot of the cell lysate was added to caspase 3 reaction bu¡er (100 mM
HEPES, pH 7.5, 10% sucrose, 0.1% CHAPS, 10 mM DTT, 0.1 mg per ml
bovine albumin, and 50 mM CPP32-AMC substrate) and incubated at
371C for 1 h. Release of the £uorescent 7-amino-4-methylcoumarin
(AMC) moiety was measured using a Hitachi F2000 spectrophotometer
(excitation, 380 nm; emission, 460 nm). The £uorescent intensity was
converted to picomoles of AMC by comparison with the £uorescent
intensity of standards of AMC (Molecular Probes, Eugene, OR). The
speci¢c activity of caspase 3 in cell lysates was then determined after the
total protein concentration of the cell lysates was measured (Protein Assay
Reagent, Bio-Rad, Hercules, CA). Relative activities were determined by
comparing the speci¢c activities derived from UVB-treated cell lysates
with those derived from untreated cell lysates.
erbB tyrosine phosphorylation Activation of erbB receptor family
was assayed from HaCaT cell lysates. Brie£y, HaCaT cells were washed
twice with ice-cold phosphate-bu¡ered saline and lysed in RIPA bu¡er
[150 mM NaCl, 50 mM TrisHCl, pH 8.0, 0.1% sodium dodecyl sulfate
(SDS), 0.5% sodium deoxycholate, 1% Nonidet P-40] containing
complete protease inhibitor cocktail (Roche), 10 mM sodium
orthovanadate, and 5 mM sodium £uoride for 20 min on ice. The cell
lysates were then harvested from the culture dishes and cellular debris was
removed by centrifugation. Tyrosine phosphorylation of the erbB receptors
was determined by immunoblotting with antiphosphotyrosine horseradish
peroxidase (HRP) conjugated antibody Ab-4 (Oncogene, Boston, MA).
Proteins were detected using the ECL-Plus chemiluminescence kit
(Amersham Pharmacia Biotech, Buckinghamshire, U.K.). To identify total
erbB1 receptors, the same immunoblot was stripped of antiphosph-
otyrosine-HRP antibodies with Western strip bu¡er (0.5 M TrisHCl,
pH 6.8; 10% SDS; 100 mM b-mercaptoethanol) and re-probed with
anti-erbB1 antibody (Cell Signaling Tech, Beverly, MA).
RESULTS
Time and dose dependence of UVB-induced apoptosis in
HaCaT cells The response of HaCaT cells to UVB irradiation
has been extensively studied. Various investigators have shown
that HaCaT cells undergo apoptosis following UVB irradiation
in a time- and dose-dependent manner. Unfortunately, the
actual dose of UVB required to induce apoptosis varies with
each report depending on the methodology of irradiation used
and the methods used to detect apoptosis. For that reason, it is
important to de¢ne the response of HaCaT cells to UVB in
these experiments. We have assessed the induction of apoptosis
using an assay that measures the activity of the caspase 3
enzyme. Previous data from our laboratory have shown that the
induction of caspase 3 perfectly correlates with the induction of
other measures of apoptosis (Barber et al, 1998; Kuhn et al, 1999;
Kumar et al, 1999; Marques et al, 2002). Using the protocol
described in Materials and Methods, apoptosis is induced in
HaCaT cells in response to doses of UVB as low as 100 J per m2
(Fig 1A) when measured at 9 h post-irradiation. The response of
HaCaT cells to UVB plateaus between 300 and 500 J per m2, so
that increasing the dose of UVB beyond these levels does not
result in any higher induction of apoptosis. When HaCaT cells
are irradiated with a UVB dose of 400 J per m2, the peak time
for the measurement of caspase 3 activity is between 8 and 10 h
following UVB exposure (Fig 1B). Therefore, in all of the studies
described below, HaCaTcells were irradiated with a dose of 400 J
per m2 and harvested at 9 h post-UVB irradiation.
Pharmaceutical inhibition of erbB family members
suppresses the induction of apoptosis by UVB Previous
studies have demonstrated that the erbB1 receptor provides a
protective function from UVB-induced apoptosis. Inhibition of
the erbB1 receptor using high-a⁄nity, speci¢c inhibitors resulted
in increased sensitivity of UVB-induced apoptosis (Stoll et al,
1998; Peus et al, 2000; Jost et al, 2001a). Because the erbB1
receptor is not the only erbB family member that becomes
Figure1. Dose- and time-dependent induction of HaCaTcell apop-
tosis by UVB. HaCaT cells were irradiated with UVB as described in
Materials and Methods using the doses indicated in the ¢gure (A) or at 400 J
per m2 for the various times listed (B). For (A), the cells were harvested and
assayed for caspase 3 enzyme activity at 9 h following irradiation.
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activated in response to UVB irradiation (Jost et al, 2000;
Olayioye et al, 2000; Bogdan and Klambt, 2001; Yarden and
Sliwkowski, 2001), we used an inhibitor of both erbB1 and
erbB2 receptors (DAPH) and assayed for the in£uence of both
receptors on the sensitivity of HaCaT cells to UVB (Noonberg
and Benz, 2000). HaCaT cells were irradiated with a dose of 0 or
400 J per m2 of UVB, and then treated with increasing
concentrations of DAPH. By treating the cells in this manner,
the e¡ectiveness of DAPH will not be a¡ected by UVB
exposure, nor will DAPH directly in£uence the e¡ective dose of
UVB delivered to the cells. Nine hours following 400 J per m2 of
UVB, plates of untreated HaCaT cells contained many apoptotic
cells (Fig 2). In contrast, increasing concentrations of DAPH
resulted in fewer apoptotic cells following UVB irradiation. At
concentrations of 10 or 30 mM DAPH, the irradiated HaCaT cells
were identical in appearance to the unirradiated, matched control
cells. Although HaCaTcells treated with 30 mMDAPH contained
an increased number of intracellular vacuoles, these vacuoles were
seen in both irradiated and unirradiated cells and thus were not
in£uenced by UVB exposure. The inhibitory e¡ect of DAPH on
UVB-induced apoptosis was con¢rmed by assaying for the
activity of the apoptosis-induced enzyme caspase 3 (Fig 3A).
The addition of DAPH to unirradiated HaCaT cells had no
e¡ect on the induction of caspase 3 enzyme activity at any
concentration of DAPH. Also, the addition of 1 mM DAPH did
not in£uence the induction of apoptosis following a dose of 400 J
per m2. Starting with 5 mM DAPH, however, there was a
reciprocal decrease in caspase 3 speci¢c activity with increasing
concentrations of DAPH. At 10 mM DAPH, the induction of
caspase 3 speci¢c activity by UVB was reduced by 65%, and at
20 mM DAPH it was reduced by 78%. No adverse e¡ects on
HaCaT cell morphology were observed using 20 mM DAPH.
UVB has been demonstrated to activate a variety of cell surface
receptors in the absence of ligand (Sachsenmaier et al, 1994;
Huang et al, 1996). Therefore, the e¡ect of DAPH on the
Figure 2. The erbB family inhibitor DAPH reduces the induction
of apoptosis by UVB. HaCaT cells were irradiated with a dose of 0 or
400 J per m2 UVB. Immediately following irradiation, the cells were trea-
ted with 0, 1, 5, 10, or 30 mM DAPH. Cells were photographed 9 h follow-
ing UVB irradiation.
Figure 3. Inhibition of erbB family receptors reduces the induction
of apoptosis by UVB. HaCaTcells were irradiated with a dose of 0 or 400
J per m2 UVB. Immediately following irradiation, the cells were treated
with 0, 1, 5, 10, or 20 mM (A) DAPH, (B) AG 1295, or (C) combinations
of AG 825 and AG 1478 as indicated. Cells were harvested 9 h following
UVB irradiation and cell lysates were assayed for caspase 3 enzyme activity.
Error bars signify (þ /^) standard deviation and are representative of two
or three di¡erent experiments. In (C), the caspase 3 speci¢c activity from
HaCaT cells treated with AG 825 or AG 1478 and irradiated with 400 J per
m2 of UVB was not signi¢cantly di¡erent from the caspase 3 speci¢c ac-
tivity of untreated HaCaT cells irradiated with 400 J per m2 of UVB (p4
0.05, Student t test). Similarly, there was no signi¢cant di¡erence between
the caspase 3 speci¢c activities of HaCaT cells treated with DAPH or AG
825 and AG 1478 that were irradiated with 400 J per m2 of UVB (p 4
0.05). There was a signi¢cant di¡erence, however, between HaCaT cells
treated with DAPH or AG 825 and AG 1478 irradiated with 400 J per m2
and HaCaTcells that were untreated and irradiated with 400 J per m2 UVB
(po 0.05).
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induction of UVB-induced apoptosis could be a generalized
response to the ‘‘capping’’ phenomenon of cell surface receptors
to UVB exposures. To examine this possibility, we used a small
molecule inhibitor of the platelet-derived growth factor receptor
(AG 1295) to see if the e¡ects we described for the erbB family
receptors were speci¢c for DAPH or were more generalized to all
tyrphostin-like molecules. In contrast to the results we describe
for DAPH, AG 1295 had little to no e¡ect on UVB-induced
apoptosis (Fig 3B). This result implies that the e¡ect of DAPH
on UVB-induced apoptosis is speci¢c for the inhibition of erbB
family receptors.
The tyrosine kinase activity of the erbB1 receptor can be
speci¢cally inhibited by the drug AG 1478, whereas the erbB2
tyrosine kinase activity is suppressed by AG 825. If DAPH was
able to suppress UVB-induced apoptosis via its ability to inhibit
both erbB1 and erbB2 tyrosine kinase activities, then treating
HaCaT cells with a combination of AG 1478 and AG 825 should
yield similar results to DAPH.Treatment of HaCaTcells with AG
825 or AG 1478 individually resulted in a statistically insigni¢cant
decrease in UVB-induced apoptosis (Fig 3C). In contrast, when
HaCaTcells were UVB-irradiated and immediately treated with a
combination of AG 825 and AG 1478, there was a protection of
UVB-induced apoptosis similar to that in HaCaT cells that were
treated with DAPH (Fig 3C). These data demonstrate that the
simultaneous inhibition of both erbB1 and erbB2 tyrosine
kinase activities leads to a suppression of UVB-induced
apoptosis.
The inhibitory activity of DAPH was con¢rmed by analyzing
the tyrosine phosphorylation status of erbB family receptors.
HaCaT cells were treated with DAPH for 1 h, and subsequently
erbB receptors were activated by treating the cells with EGF or
UVB. As shown in Fig 4, treatment of HaCaT cells with either
EGF or UVB led to the tyrosine phosphorylation of erbB family
receptors. Due to the potential heterodimerization of erbB1 and
erbB2 receptors and their similar apparent molecular weights,
we cannot distinguish between erbB1 and erbB2 receptor
activation in these assays. Pretreatment of the HaCaT cells with
DAPH, however, completely inhibited the activation of erbB
receptors following UVB irradiation and substantially reduced
the phosphorylation of erbB receptors after the addition of EGF.
These data con¢rmed the validity of using the drugs for their
intended purposes.
Immobilization of the erbB1 receptor also suppresses UVB-
induced apoptosis In order to con¢rm the results obtained
using the pharmaceutical inhibitor DAPH, the activity of the
erbB1 receptor was also inhibited through the use of
neutralizing antibodies prior to UVB irradiation. As erbB2
homodimers have not been described to occur in keratinocytes,
the use of a neutralizing antibody to erbB1 should suppress the
activation of both erbB1 and erbB2 due to stearic hindrance of
erbB1 mobility in the plasma membrane. This mechanical
inhibition of the erbB1 receptor will e¡ectively inhibit both the
erbB1 homodimers and erbB1:erbB2 heterodimers. Following
treatment with the neutralizing antibody, the induction of
caspase 3 activity by UVB was reduced by 70% (Fig 5), whereas
irrelevant control antibodies had no e¡ect on UVB irradiation.
UVB-induced apoptosis could also be suppressed by pretreating
the HaCaTcells with neutralizing antibodies to erbB2.These data
imply that erbB1:erbB2 heterodimers play a substantial role in
UVB-induced apoptosis, but further studies are required to
more completely delineate their relationship. Nevertheless, the
inhibition of the erbB family receptors using two di¡erent
mechanisms resulted in the suppression of UVB-induced
apoptosis.
Suppression of apoptosis by DAPH is speci¢c for
UVB Apoptosis can be induced in cells by a variety of
di¡erent types of factors. To determine if the e¡ect of DAPH on
UVB-induced apoptosis was a generalized response to apoptotic
factors or if it was speci¢c for UVB, we used an alternative
method to induce apoptosis in HaCaT cells. The tumor-necrosis-
factor-related apoptosis-inducing ligand (TRAIL) has been
shown to induce apoptosis in HaCaT cells through the activation
of the death receptors DR4 and DR5 (Kothny-Wilkes et al, 1998;
Southall et al, 2001). HaCaT cells were treated with DAPH or the
neutralizing anti-erbB1 antibody for 30 min prior to the addition
of TRAIL. As seen in Fig 6, the addition of DAPH or the
neutralizing antibody did not in£uence the induction of
apoptosis byTRAIL. This suggests that the suppressive e¡ects of
DAPH on the induction of apoptosis are limited to a protective
response speci¢cally to UVB.
DISCUSSION
Exposure of HaCaT keratinocytes to UVB leads to the induction
of apoptosis in a time- and dose-dependent manner, as measured
Figure 4. DAPH inhibits UVB-dependent erbB family receptor
tyrosine phosphorylation. HaCaT cells were pretreated with 10 mM
DAPH or left untreated for 60 min.The keratinocytes were then untreated,
treated with 20 ng per ml EGF, or exposed to 400 J per m2 of UVB. Cells
were harvested 15 min following EGF or UVB treatment and cell lysates
were assayed for erbB1 tyrosine phosphorylation. Equal loading of each cell
lysate was con¢rmed by stripping each immunoblot and reprobing with
erbB1-speci¢c antibodies.
Figure 5. Neutralizing antibodies to erbB1 and erbB2 suppress
UVB-induced apoptosis. HaCaT cells were untreated or treated with 1
mg per ml neutralizing anti-erbB1 antibody, 1 mg per ml neutralizing anti-
erbB2 antibody, or 1 mg per ml nonspeci¢c mouse IgG antibody for
30 min. The cells were then irradiated with a dose of 0 or 400 J per m2
UVB. Cells were harvested 9 h following UVB irradiation and cell lysates
were assayed for caspase 3 enzyme activity. Error bars signify (þ /^) stan-
dard deviation and are representative of two to three di¡erent experiments.
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by increases in caspase 3 activity. Maximal induction of UVB-in-
duced apoptosis in our experimental set-up occurred at a UVB
dose of 400 J per m2, 9 h following irradiation. Treatment of Ha-
CaT cells with either a pharmaceutical or a physical inhibitor of
the erbB receptor family, however, could substantially inhibit the
induction of apoptosis. The protective e¡ect on apoptosis by the
erbB receptor inhibitors was speci¢c for UVB-induced apoptosis
because the inhibitors had no e¡ect on the induction of apoptosis
byTRAIL.
Although the exact pathway by which UVB induces apoptosis
has yet to be elucidated, clues to the mechanism are beginning to
emerge. It should not be too surprising that many of the path-
ways that have been identi¢ed are speci¢c for certain types of
cells. For example, treatment of primary NHK with hepatocyte
growth factor/scatter factor will abrogate UVB-induced apopto-
sis via phosphatidyl inositol-3 kinase and Akt activation (Mildner
et al, 2002). Even though the Akt pathway is functionally intact in
HaCaTcells, hepatocyte growth factor/scatter factor does not pro-
vide any protection from UVB-induced apoptosis. There are
some similarities in the UVB response of HaCaT cells and
NHK, however. Inhibition of the stress-response mitogen-acti-
vated protein kinase p38 leads to a partial suppression of UVB-
induced apoptosis in both NHK and HaCaT cells (Shimizu et al,
1999; Assefa et al, 2000).1 Similarly, the protective e¡ect of erbB
family receptors on UVB-induced apoptosis in HaCaT cells that
was presented in this paper can also be observed in NHK.
In NHK cells, the outcome of erbB family inhibitors and
UVB was determined by the proliferative status of the keratino-
cytes.2 If NHKs were actively proliferating, then inhibition of
erbB receptors led to a protection from UVB-induced apoptosis.
A similar phenomenon has been described for HaCaTcells where
the overexpression of the immediate early gene product IEX-1
led to enhanced proliferative capacity and a corresponding in-
crease in their sensitivity to UVB-induced apoptosis (Schilling
et al, 2001). Integrating these results suggests that actively prolifer-
ating HaCaT cells are more sensitive to UVB-induced apoptosis
due to their increased mitogenic potential possibly involving in-
creased erbB receptor activity.
Previous studies looking at erbB1 inhibitors have demonstrated
that inhibition of erbB1 tyrosine kinase activity leads to a
sensitization of UVB-induced apoptosis (Stoll et al, 1998; Peus et
al, 2000; Jost et al, 2001a). These results appear to be in contrast to
the data presented in this paper, which describe a protective e¡ect
of erbB receptor inhibition of UVB-induced apoptosis. It has
also been reported that inhibitors of cellular tyrosine kinase activ-
ity in HaCaTcells will prevent UVB-induced apoptosis (Fukuna-
ga et al, 2001). This dissimilitude of results can be resolved by the
di¡erence in the inhibitors used in each of the studies. In this pa-
per, a pharmaceutical inhibitor that inactivates both the erbB1
and erbB2 receptors was used. Previous studies describing a pro-
tective function for the erbB1 receptor have used highly speci¢c
small molecules that speci¢cally inhibit the erbB1 receptor activ-
ity without a¡ecting erbB2 receptor activity. The importance of
these results is evident as UVB has been reported to cause the
tyrosine phosphorylation of both the erbB1 and erbB2 receptors.
erbB1:erbB2 heterodimerization has been described in other
epithelial cells and is known to alter erbB1 function (Muthuswamy
et al, 1999; 2001; Zhang et al, 2002). Hence, we hypothesize that
the dual speci¢city of DAPH on erbB1 and erbB2 tyrosine kinase
activity alters the response of the HaCaTcells to UVB irradiation
in a manner that is distinctly di¡erent from inhibition of erbB1
alone.
The analysis of erbB receptor function in keratinocytes, and
speci¢cally HaCaTcells, is only just beginning. Similar to NHKs,
HaCaT cells uniformly express the erbB1, erbB2, and erbB3 fa-
mily members (Marques et al, 1999). Following ligand binding,
heterodimerization of all combinations of these three receptors
has been described. It is still unclear, however, what the conse-
quences of heterodimerization are. Heterodimerization of erb-
B1:erbB2 can lead to changes in cellular localization, substrate
interactions, and receptor stability compared to erbB1 homodi-
mers. For instance, Zhang et al (2002) have shown that erbB1
homodimers lead to raf recruitment to the cell membrane and
raf activation, followed by rapid dissociation of raf and erbB1
from the membrane. In contrast, erbB1:erbB2 heterodimers also
lead to raf membrane recruitment and activation, but raf and the
erbB receptors are maintained at the cell surface. Interestingly, we
have preliminary evidence that UVB activation of erbB receptors
remain cell surface associated and remain activated for extended
periods of time (personal communication). Therefore, we are ac-
tively pursuing the possibility of UVB-induced heterodimeriza-
tion of erbB1 and erbB2.
In conclusion, we have presented unique data that suggest that
the inhibition of the erbB family of tyrosine kinase receptors
protects HaCaT cells from UVB-induced apoptosis. We further
propose that both the erbB1 and erbB2 receptor tyrosine kinase
activity must be inactivated to observe the inhibition of UVB-
induced apoptosis and that these results have implications
for UVB exposure of actively proliferating keratinocytes in the
epidermis.
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